Radiation-Drug Combinations to Improve Clinical Outcomes and Reduce Normal Tissue Toxicities: Current Challenges and New Approaches: Report of the Symposium Held at the 63rd Annual Meeting of the Radiation Research Society, 15–18 October 2017; Cancun, Mexico-Reference-Cited by-同舟云学术

Radiation-Drug Combinations to Improve Clinical Outcomes and Reduce Normal Tissue Toxicities: Current Challenges and New Approaches: Report of the Symposium Held at the 63rd Annual Meeting of the Radiation Research Society, 15–18 October 2017; Cancun, Mexico

Published:2018-10-01 Issue:4 Volume:190 Page:350
ISSN:0033-7587
Container-title:Radiation Research
language:
Short-container-title:Radiation Research

Author:

Falls Kelly C.¹,Sharma Ricky A.²,Lawrence Yaacov R.³,Amos Richard A.⁴,Advani Sunil J.⁵,Ahmed Mansoor M.⁶,Vikram Bhadrasain⁶,Coleman C. Norman⁶,Prasanna Pataje G.⁶

Affiliation:

1. Free Radical and Radiation Biology Program, Department of Radiation Oncology, Carver College of Medicine, Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, Iowa 52242

2. NHR University College of London Hospitals Biomedical Research Center, UCL Cancer Institute, University College London, United Kingdom

3. Center for Translational Research in Radiation Oncology, Department of Radiation Oncology, Sheba Medical Center affiliated with Tel Aviv University, Tel HaShomer 5265601, Israel

4. Proton and Advanced Radiotherapy Group, Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom

5. Department of Radiation Medicine and Applied Sciences, University of California, San Diego, Moores Cancer Center, La Jolla, California 92093

6. National Cancer Institute, Division of Cancer Treatment and Diagnosis, Radiation Research Program, Bethesda, Maryland 20892

Publisher

Radiation Research Society

Subject

Radiology Nuclear Medicine and imaging,Radiation,Biophysics

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Condensed Matter Systems Exposed to Radiation: Multiscale Theory, Simulations, and Experiment;Chemical Reviews;2024-06-06

2. Adjuvant Novel Nanocarrier-Based Targeted Therapy for Lung Cancer;Molecules;2024-02-29

3. SMAD4 loss predicts worse overall and distant metastasis‐free survival in patients with resected pancreatic adenocarcinoma;Cancer;2023-10-12

4. A High Throughput Screen with a Clonogenic Endpoint to Identify Radiation Modulators of Cancer;Radiation Research;2022-12-29

5. A high throughput screen with a clonogenic endpoint to identify radiation modulators of cancer;2022-05-25